Tetramisole, developed as a racemic mixture (equal parts dextro- and levorotatory isomers), was an early broad-spectrum anthelmintic. Levamisole, its purified S-(-)-isomer, emerged as a superior alternative with 1–2 times higher potency and reduced toxicity due to selective binding to parasitic neuromuscular receptors. Both drugs work by:
Inhibiting succinate dehydrogenase, disrupting anaerobic energy metabolism in parasites.
Stimulating nicotinic receptors, causing paralysis and expulsion of live worms.
Table: Key Differences Between Tetramisole and Levamisole
| Parameter | Tetramisole | Levamisole |
|---|---|---|
| Efficacy | Moderate (broad-spectrum) | 1–2× higher; 100% efficacy against swine roundworms |
| Safety Margin | Narrow (LD₅₀ in pigs: 40 mg/kg subcut.) | Wider but species-dependent (avoid in horses/camels) |
| Current Status | Obsolete due to toxicity | First-line for livestock/carnivores |
Broad-Spectrum Activity: Highly effective against:
Gastrointestinal nematodes (e.g., Haemonchus, Ostertagia in cattle)6.
Lungworms (Dictyocaulus).
Ascarids in swine (100% elimination at 7.5 mg/kg).
Dual Functionality: Enhances T-cell immunity, aiding parasite clearance and reducing secondary infections.
Operational Flexibility: Administered orally (feed/water), subcutaneously, or intramuscularly.
Cost-Effectiveness: Low dose (e.g., cattle: 7.5 mg/kg) suits mass deworming programs.
Species-Specific Toxicity:
Cattle: Salivation, injection-site swelling.
Sheep/Goats: Excitement, depression, or hypersalivation.
Dogs/Cats: Vomiting, neurotoxicity (panting, head tremors), agranulocytosis.
Environmental Hazard: Highly toxic to aquatic life (fish, shrimp).
Drug Interactions:
Fatal with chloramphenicol or organophosphates.
Avoid in stressed animals (post-vaccination, pregnancy).
Cattle/Sheep: 7.5 mg/kg orally or subcutaneously.
Swine: 7.5–8 mg/kg (oral/injection); 100% efficacy against Ascaris suum.
Poultry: 24 mg/kg in water.
Dogs/Cats: 10 mg/kg orally.
Withdrawal Periods:
Cattle: 14 days; Sheep/Swine: 28 days; Poultry: 28 days.
Milk animals: Contraindicated due to excretion in milk.
Overdose Management: Atropine as antidote for cholinergic effects.
Efficacy-Safety Balance: Lower neurotoxicity vs. tetramisole by eliminating inactive R-isomer.
Immunomodulation: Boosts herd immunity during parasite outbreaks.
Economic Viability: Costs ~50% less than newer benzimidazoles per dose.
Q: Can levamisole be used in poultry?
A: Yes, at 24 mg/kg in drinking water—effective against roundworms and hookworms.
Q: Why avoid levamisole in horses?
A: Horses show high sensitivity; even therapeutic doses cause neurotoxicity or death.
Q: What are severe side effects in dogs?
A: Immune-mediated skin necrosis, agranulocytosis, and pulmonary edema—immediate vet care needed.
Q: Is resistance a concern with levamisole?
A: Yes, rotating with benzimidazoles (e.g., albendazole) prevents resistance in nematodes.
Levamisole remains a cornerstone anthelmintic due to its:
① High efficacy against key nematodes;
② Immune-boosting properties;
③ Low-cost mass administration.
Tetramisole is obsolete due to unbalanced isomer toxicity. Future research should explore levamisole-adjuvant combinations to offset resistance risks while leveraging immunomodulation for herd health. For aquatic environments, strict disposal protocols are non-negotiable
